NM_006073.4:c.239C>T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_006073.4(TRDN):​c.239C>T​(p.Ser80Phe) variant causes a missense change. The variant allele was found at a frequency of 0.0000585 in 1,401,120 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00016 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000047 ( 1 hom. )

Consequence

TRDN
NM_006073.4 missense

Scores

6
9
4

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:3

Conservation

PhyloP100: 5.76

Publications

1 publications found
Variant links:
Genes affected
TRDN (HGNC:12261): (triadin) This gene encodes an integral membrane protein found in skeletal and cardiac muscle. The encoded protein plays a role in skeletal muscle excitation-contraction coupling as part of the calcium release complex and is required for normal skeletal muscle strength. This protein indirectly links triads and microtubules in skeletal muscle. Mutations in this gene are associated with cardiac arrythmia syndrome and some variants in this gene may be associated with sudden cardiac death. [provided by RefSeq, May 2022]
TRDN Gene-Disease associations (from GenCC):
  • catecholaminergic polymorphic ventricular tachycardia
    Inheritance: AD, AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • catecholaminergic polymorphic ventricular tachycardia 5
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • familial long QT syndrome
    Inheritance: AR Classification: STRONG Submitted by: G2P
  • long QT syndrome
    Inheritance: AR Classification: STRONG Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010376781).
BP6
Variant 6-123548606-G-A is Benign according to our data. Variant chr6-123548606-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 449704.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00016 (23/143748) while in subpopulation AMR AF = 0.00139 (20/14366). AF 95% confidence interval is 0.000922. There are 0 homozygotes in GnomAd4. There are 15 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRDNNM_006073.4 linkc.239C>T p.Ser80Phe missense_variant Exon 3 of 41 ENST00000334268.9 NP_006064.2 Q13061-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRDNENST00000334268.9 linkc.239C>T p.Ser80Phe missense_variant Exon 3 of 41 1 NM_006073.4 ENSP00000333984.5 Q13061-1

Frequencies

GnomAD3 genomes
AF:
0.000160
AC:
23
AN:
143642
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000535
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00139
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000517
GnomAD2 exomes
AF:
0.000404
AC:
35
AN:
86694
AF XY:
0.000253
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00753
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000541
GnomAD4 exome
AF:
0.0000469
AC:
59
AN:
1257372
Hom.:
1
Cov.:
35
AF XY:
0.0000357
AC XY:
22
AN XY:
615930
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26134
American (AMR)
AF:
0.00350
AC:
55
AN:
15718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
20412
East Asian (EAS)
AF:
0.00
AC:
0
AN:
31546
South Asian (SAS)
AF:
0.00
AC:
0
AN:
51000
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
44624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5092
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1011678
Other (OTH)
AF:
0.0000782
AC:
4
AN:
51168
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000160
AC:
23
AN:
143748
Hom.:
0
Cov.:
31
AF XY:
0.000215
AC XY:
15
AN XY:
69738
show subpopulations
African (AFR)
AF:
0.0000534
AC:
2
AN:
37488
American (AMR)
AF:
0.00139
AC:
20
AN:
14366
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3398
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5054
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4578
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9408
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
284
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
66314
Other (OTH)
AF:
0.000511
AC:
1
AN:
1956
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.523
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.000359
ExAC
AF:
0.000520
AC:
58
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Sep 08, 2017
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The S80F variant has not been published as pathogenic or been reported as benign to our knowledge. The S80F variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. The Exome Aggregation Consortium reports S80F was observed in 13/1,450 (0.9%) alleles from individuals of Latino background, including one homozygous individual (Lek et al., 2016). -

Catecholaminergic polymorphic ventricular tachycardia 5 Uncertain:1
Mar 30, 2021
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TRDN NM_006073.3 exon 3 p. Ser80Phe (c.239C>T): This variant has not been reported in the literature and is present in 0.66% (35/5298) of Latino alleles in the Genome Aggregation Database, including one homozygote (http://gnomad.broadinstitute.org/variant/6-123869751-G-A). This variant is present in ClinVar (Variation ID:449704). Evolutionary conservation and computational predictive tools suggest that this variant may impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -

TRDN-related disorder Benign:1
Sep 26, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Catecholaminergic polymorphic ventricular tachycardia 1 Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Aug 30, 2023
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.79
BayesDel_addAF
Benign
0.0094
T
BayesDel_noAF
Pathogenic
0.25
CADD
Pathogenic
26
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.47
T;.;.;.
Eigen
Pathogenic
0.82
Eigen_PC
Pathogenic
0.78
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Uncertain
0.87
D;D;D;D
M_CAP
Benign
0.072
D
MetaRNN
Benign
0.010
T;T;T;T
MetaSVM
Uncertain
0.11
D
MutationAssessor
Uncertain
2.6
M;M;.;M
PhyloP100
5.8
PrimateAI
Uncertain
0.66
T
PROVEAN
Uncertain
-2.9
D;.;D;D
REVEL
Uncertain
0.34
Sift
Pathogenic
0.0
D;.;D;D
Sift4G
Pathogenic
0.0010
D;D;D;D
Polyphen
1.0
D;.;.;.
Vest4
0.71
MVP
0.77
ClinPred
0.23
T
GERP RS
5.3
Varity_R
0.55
gMVP
0.42
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs181287533; hg19: chr6-123869751; API